ilepcimide has been researched along with coumaperine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balamurali, MM; Basu, B; Doble, M; Munussami, P; Muthuraman, S; Saravana Kumar, R; Sinha, S; Vasavi, CS; Waidha, KM | 1 |
| Cai, X; Chen, L; Hong, F; Kuang, S; Li, Y; Ma, X; Qi, W; Shi, M; Wang, L; Xu, R; Xue, L; Ye, H; Zhang, R | 1 |
2 other study(ies) available for ilepcimide and coumaperine
| Article | Year |
|---|---|
Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies.
Topics: Antioxidants; Arachidonate 5-Lipoxygenase; Catalytic Domain; Drug Design; Enzyme Assays; Humans; Hydroxyurea; Lipoxygenase Inhibitors; Molecular Docking Simulation; Molecular Structure; Peroxidases; Piperidines; Structure-Activity Relationship | 2019 |
Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/keap1 pathway.
Topics: Alkaloids; Animals; Apoptosis; Behavior, Animal; Benzodioxoles; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Kelch-Like ECH-Associated Protein 1; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; NF-E2-Related Factor 2; Parkinson Disease; PC12 Cells; Piperidines; Polyunsaturated Alkamides; Rats; Structure-Activity Relationship | 2020 |